These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16794435)

  • 1. The use of intravitreal corticosteroids, evidence-based and otherwise.
    Conti SM; Kertes PJ
    Curr Opin Ophthalmol; 2006 Jun; 17(3):235-44. PubMed ID: 16794435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone acetonide: a change in a paradigm.
    Jonas JB
    Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
    Jonas JB; Kreissig I; Degenring R
    Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.
    Jonas JB; Schlichtenbrede F
    Eye (Lond); 2008 Jul; 22(7):869-73. PubMed ID: 17304257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
    Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
    Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of intraocular corticosteroids.
    Kiernan DF; Mieler WF
    Expert Opin Pharmacother; 2009 Oct; 10(15):2511-25. PubMed ID: 19761356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal steroids for macular edema: the past, the present, and the future.
    Cunningham MA; Edelman JL; Kaushal S
    Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intravitreal high-dose reinjections of triamcinolone acetonide.
    Jonas JB; Degenring R; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Dec; 138(6):1054-5. PubMed ID: 15629306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
    Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
    Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
    Kawaji T; Takano A; Inomata Y; Sagara N; Iwao K; Inatani M; Fukushima M; Tanihara H
    Br J Ophthalmol; 2008 Jan; 92(1):81-3. PubMed ID: 17965103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.